Somer Baburek of Hera Biotech

Endometriosis affects about 1 in 10 reproductive-age women and remains a major driver of pelvic pain and infertility. In the U.S., cervical cancer is expected to cause about 13,490 new invasive cases and 4,200 deaths in 2026. Earlier detection matters: cervical screening can catch precancer before it becomes cancer, and localized cervical cancer has a 91.4% 5-year survival versus 19.5% once it is distant. Earlier recognition of endometriosis can also help patients reach pain and fertility-directed treatment sooner. Somer Baburek, MBA of Hera Biotech joined me to talk about how they are bringing innovation to the point of care, allowing physicians to identify these diagnoses far sooner, allowing more flexibility in treatment and follow-up diagnostics for their patients. hashtag#kineticinnovators hashtag#herabiotechhashtag#EndometriosisAwareness hashtag#CervicalCancerAwareness hashtag#EarlyDetection